HAS Healthcare Advanced Synthesis SA (Biasca, Switzerland) celebrates 40 years of Excellence in Pharmaceutical Development and Manufacturing
Biasca, Switzerland, February 27th, 2024 – HAS Healthcare Advanced Synthesis SA is delighted to announce a significant milestone in its journey – its 40th anniversary! For four decades, HAS Healthcare Advanced Synthesis has stood as a beacon of excellence in the international chemical-pharmaceutical industry, providing unparalleled services in pharmaceutical development and manufacturing.
Founded in 1984, the family-owned HAS Healthcare Advanced Synthesis offers the best CDMO standards by delivering active pharmaceutical ingredients (APIs), highly potent active pharmaceutical ingredients (HPAPIs), and anticancer compounds to pharmaceutical and biotechnology companies worldwide. The commitment to innovation, quality, and customer satisfaction has been the cornerstone of its success.
1984 -> 2023
HAS Healthcare Advanced Synthesis is recognized as a Contract Development Manufacturing Organization (CDMO) offering a comprehensive range of customized services, from research development to full-scale manufacturing. The cutting-edge production facility, situated in Biasca, Switzerland, serves as the nucleus of our operations and undergoes regular inspections by Swissmedic, FDA, PMDA, and other global regulatory entities.
HAS Healthcare Advanced Synthesis offers production capabilities ranging from a few hundred grams to tens of kilograms for highly potent active pharmaceutical ingredients (HPAPI) and anticancer compounds, and from kilograms to tens of tons for active pharmaceutical ingredients (APIs). Our facilities are fully dedicated to cGMP production, ensuring customized solutions at the highest standards of quality and compliance.
Dr. Waldo Mossi, PhD, CEO, HAS Healthcare Advanced Synthesis, commented:
"Our primary focus is consistently enhancing our production capabilities to deliver the highest quality products to our clients. Concurrently, we have a strong commitment to the environment, continually striving to boost sustainability year by year. This commitment is evidenced by our ongoing investments in innovative technologies aimed at minimizing our carbon footprint to preserve the environment."
On this special anniversary, a heartfelt thank you and profound gratitude to our loyal clients, esteemed partners and dedicated employees for their unwavering loyalty, continuous support and trust. We look forward to reaching future achievements together and to witnessing more milestones.”
Looking ahead, we, at HAS Healthcare Advanced Synthesis, remain committed to driving innovation, fostering partnerships, and delivering excellence in every aspect of our operations. With new opportunities on the horizon, there is excitement about the journey ahead and confidence in our ability to continue making a positive impact on global healthcare.
Once again, we express our sincere gratitude to each and every one for your continued support. Here's to our 40 years of excellence, and to many more years of innovation, collaboration, and success to come!
For more information visit our website https://www.hashealthcare.com/ and follow us on Linkedin.
Contact Press Office
HAS Healthcare Advanced Synthesis
Biasca, Switzerland
Giacomo Braglia
Tel: +41 (0) 91 873 94 00
Email: [email protected]